AI assistant
DEXCOM INC — Director's Dealing 2020
Sep 17, 2020
30198_dirs_2020-09-16_85d0654e-677a-42c9-ad1b-85ba477c293d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-15
Reporting Person: ALTMAN STEVEN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-15 | Common Stock | S | 30000 | $393.92 | Disposed | 12980 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 806 | Direct |
Footnotes
F1: The Reporting Person contributed 30,000 shares of the Issuer's Common Stock to an exchange fund in exchange for shares of the exchange fund. The Issuer's Common Stock was valued at $393.92 per share for the purpose of determining the number of shares of the exchange fund issuable to the Reporting Person. The shares contributed to the exchange fund are non-redeemable, except with the consent of the Company, for as long as the Reporting Person is a director or affiliate of the Issuer.
F2: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.